Dogwood Therapeutics, Inc.(DWTX)
Biotechnology
Neuroscience Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-08-22 | Pridgen William Director | Purchase | +15,335 | +2.06%761,279 | $1.30 | $19,992 | View SEC filing | |
| 2023-08-18 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Purchase | +25,000 | +77.02%57,461 | $1.25 | $31,245 | View SEC filing | |
| 2022-12-12 | Whitley Richard James Director | Sale | -1,800 | -72.00%700 | $0.26 | $466 | View SEC filing | |
| 2022-05-24 | Walsh Angela SVP OF FINANCE | Purchase | +2,000 | +200.00%3,000 | $4.58 | $9,150 | View SEC filing | |
| 2022-05-24 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Purchase | +7,500 | +30.05%32,461 | $4.52 | $33,900 | View SEC filing | |
| 2022-05-19 | Whitley Richard James Director | Purchase | +500 | +25.00%2,500 | $4.53 | $2,263 | View SEC filing | |
| 2022-05-19 | Pridgen William Director | Purchase | +241 | +0.66%36,710 | $4.50 | $1,085 | View SEC filing | |
| 2022-05-18 | Pridgen William Director | Purchase | +13,450 | +58.43%36,469 | $4.38 | $58,914 | View SEC filing | |
| 2022-03-30 | Pridgen William Director | Purchase | +600 | +2.68%23,019 | $4.94 | $2,964 | View SEC filing | |
| 2022-03-24 | Pridgen William Director | Purchase | +2,197 | +10.86%22,419 | $5.46 | $12,002 | View SEC filing | |
| 2022-01-28 | Pridgen William Director | Purchase | +4,180 | +28.74%18,722 | $5.98 | $24,998 | View SEC filing | |
| 2022-01-07 | De La Rosa Abel Director | Purchase | +4,000 | +100.00%4,000 | $5.90 | $23,584 | View SEC filing | |
| 2022-01-07 | Whitley Richard James Director | Purchase | +1,800 | +900.00%2,000 | $5.72 | $10,296 | View SEC filing | |
| 2022-01-05 | Keefer David R Director | Purchase | +5,000 | +100.00%5,000 | $5.79 | $28,975 | View SEC filing | |
| 2022-01-04 | Pridgen William Director | Purchase | +2,215 | +17.97%14,542 | $5.43 | $12,034 | View SEC filing | |
| 2022-01-04 | Thomas John C Director | Purchase | +1,000 | +100.00%1,000 | $5.65 | $5,650 | View SEC filing | |
| 2021-12-23 | Whitley Richard James Director | Purchase | +200 | +100.00%200 | $5.72 | $1,145 | View SEC filing | |
| 2021-12-22 | Pridgen William Director | Purchase | +8,827 | +252.20%12,327 | $5.66 | $49,997 | View SEC filing | |
| 2021-12-22 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Purchase | +5,000 | +25.05%24,961 | $5.52 | $27,615 | View SEC filing | |
| 2021-07-09 | Pridgen William Director | Purchase | +942 | +0.13%710,734 | $6.32 | $5,951 | View SEC filing | |
| 2021-04-07 | Duncan Gregory Scott Chief Executive Officer | Purchase | +382 | +1.95%19,961 | $6.36 | $2,429 | View SEC filing | |
| 2021-04-06 | Duncan Gregory Scott Chief Executive Officer | Purchase | +15,675 | +401.51%19,579 | $6.17 | $96,757 | View SEC filing | |
| 2021-04-06 | Duncan Gregory Scott Chief Executive Officer | Purchase | +15,675 | +401.51%19,579 | $6.17 | $96,757 | View SEC filing | |
| 2021-02-01 | Walsh Angela VP of Finance | Purchase | +1,000 | +100.00%1,000 | $7.30 | $7,300 | View SEC filing | |
| 2021-02-01 | Pridgen William Director | Purchase | +3,500 | +100.00%3,500 | $7.47 | $26,145 | View SEC filing |
1-25 of 26